Foley Partner Margaret Nelson was quoted in a Private Funds CFO article, “What Gensler’s tough talk could mean for private funds,” about how both regulators and lawmakers are bringing attention to the need for stricter regulations for private funds.
Nelson said, “There has been such a push under the last administration on retail investment advisers, and Gensler kind of hinted that he’s thinking more about private funds.”
Nelson adds, “You can see in Gensler’s most recent testimony the focus on pensions. There’s an awareness that private funds have mom-and-pop investors behind them, even if indirectly. And it seems like they’re focusing on newly registered IAs, as well as IAs that haven’t been examined in a while.”
(subscription required)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”